Aprepitant ready-to-use injection emulsion compositions
US11517522B2 · kind B2 · utility
0Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2021 |
| Grant date | Dec 6, 2022 |
| Priority date | — |
| Expiry date | Jan 13, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M5/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an emulsion composition comprising aprepitant for treatment of emesis. Particularly, the invention is a ready-to-use emulsion compositions comprising aprepitant and medium chain triglycerides for administration by intravenous infusion, wherein the emulsion composition is also free of ethanol. Further, the invention also provides processes of preparing such compositions and their use for the prevention and control of acute and delayed chemotherapy-induced nausea and vomiting, and/or for prevention of postoperative nausea and vomiting.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.